# Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study

> **NCT04933630** · — · COMPLETED · sponsor: **Adams Clinical** · enrollment: 27 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)

## Key facts

- **NCT ID:** NCT04933630
- **Lead sponsor:** Adams Clinical
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-10-05
- **Final completion:** 2022-10-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04933630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04933630, "Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04933630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*